, Volume 68, Issue 11–12, pp 949–954 | Cite as

LC Method for Quantification of Lutein in Rat Plasma: Validation, and Application to a Pharmacokinetic Study

  • Marina V. Karlina
  • Olga N. Pozharitskaya
  • Alexander N. Shikov
  • Vera M. Kosman
  • Marina N. Makarova
  • Valery G. Makarov


A reversed-phase LC method has been developed for quantitative analysis of lutein in rat plasma and applied to a study of the pharmacokinetics of lutein in rats. From a variety of compounds and solvents tested, astaxanthin was selected as the internal standard. n-Hexane was found to be the best solvent for extracting lutein from plasma. LC analysis of the extracts was performed on a C18 column equipped with a guard pre-column. Linearity was good (r > 0.99) over the range 10–100 ng mL−1. Recovery from plasma was 82.7–92.9% the intra-day and inter-day precision were always better than 3%. The limits of detection (LOD) and quantification (LOQ) were 2.5 and 8.3 ng mL−1, respectively. The LC method was used to quantify lutein and zeaxanthin in rat plasma in a 36-h pharmacokinetic study in which experimental rats received a single oral dose of lutein (20 mg kg−1). The results are presented.


Column liquid chromatography Lutein Pharmacokinetics Rat plasma 



The authors are grateful to Ekomir Company (Moscow, Russia) for financial support.


  1. 1.
    Breithaupt DE, Bamedi A (2001) J Agric Food Chem 49:2064–2070CrossRefGoogle Scholar
  2. 2.
    Schalch W, Dayhaw-Barker P, Barker FM (1999) The carotenoids in the human macula. In: Taylor A (ed) Nutritional and environmental influences on the eye. CRC Press, Boca Raton, pp 215–250Google Scholar
  3. 3.
    Landrum JT, Bone RA (2001) Arch Biochem Biophys 385:28–40CrossRefGoogle Scholar
  4. 4.
    Krinsky NI, Landrum JT, Bone RA (2003) Ann Rev Nutr 23:171–201CrossRefGoogle Scholar
  5. 5.
    Vu HT, Robman L, Hodge A, McCarty CA, Taylor HR (2006) Invest Ophthalmol Vis Sci 47:3783–3786CrossRefGoogle Scholar
  6. 6.
    Lakshminarayana R, Raju M, Krishnakantha TP, Baskaran V (2007) J Agric Food Chem 55:6395–6400CrossRefGoogle Scholar
  7. 7.
    Bhosale P, Zhao da Y, Bernstein PS (2007) Invest Ophthalmol Vis Sci 48:543–549CrossRefGoogle Scholar
  8. 8.
    Toomey MB, McGraw KJ (2007) IOVS 48:3976–3982Google Scholar
  9. 9.
    Pfander H, Riesen R, Niggli U (1994) Pure Appl Chem 66:947–954CrossRefGoogle Scholar
  10. 10.
    Khachik F, Beecher GR, Goli MB (1991) Pure Appl Chem 63:71–80CrossRefGoogle Scholar
  11. 11.
    Itagaki S, Ogura W, Sato Y, Noda T, Hirano T, Mizuno S, Iseki K (2006) Biol Pharm Bull 29:2123–2125CrossRefGoogle Scholar
  12. 12.
    Takahashi M, Watanabe H, Kikkawa J, Ota M, Watanabe M, Sato Y, Inomata H, Sato N (2006) Anal Sci 22:1441–1447CrossRefGoogle Scholar
  13. 13.
    Su Q, Rowley KG, O’Dea K (1999) J Chromatogr B 729:191–198CrossRefGoogle Scholar
  14. 14.
    Firsov AA, Zherdev VP, Barmanova EYU, Rodionov AP, Fisenko VP (2005) Methodical instructions on organization of pre-clinical trials of pharmacokinetic of medicinal preparations. In: Khabriev RU (ed) Guideline on experimental (pre-clinical) studying of new pharmacological substances, 2nd edn. Medicine Press, Moscow, pp 217–229Google Scholar
  15. 15.
    ICH, Q2A (1994) Harmonised tripartite guideline, text on validation of analytical procedures, IFPMA. In: Proc Int Conf Harmonization, Geneva, March 1994, pp 1–5Google Scholar
  16. 16.
    ICH, Q2B (1996) Harmonised tripartite guideline, validation of analytical procedure: methodology, IFPMA. In: Proceeding of international conference of harmonization, Geneva, March 1996, pp 1–8Google Scholar

Copyright information

© Vieweg+Teubner | GWV Fachverlage GmbH 2008

Authors and Affiliations

  • Marina V. Karlina
    • 1
  • Olga N. Pozharitskaya
    • 1
    • 2
  • Alexander N. Shikov
    • 1
    • 2
  • Vera M. Kosman
    • 2
  • Marina N. Makarova
    • 1
  • Valery G. Makarov
    • 1
    • 2
  1. 1.Saint Petersburg Institute of PharmacySt. PetersburgRussia
  2. 2.Interregional Center “Adaptogen”St. PetersburgRussia

Personalised recommendations